Cantor Fitzgerald Maintains Ascendis Pharma A (ASND) Overweight Recommendation
29/4 13:39
Fintel reports that on April 28, 2023, Cantor Fitzgerald maintained coverage of Ascendis Pharma A (NASDAQ:ASND) with a Overweight recommendation....
|
|
|
29/4 13:39
Fintel reports that on April 28, 2023, Cantor Fitzgerald maintained coverage of Ascendis Pharma A (NASDAQ:ASND) with a Overweight recommendation....